Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Thrombosis Journal 20 (2022): 31.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Warkentin, Lisette
Hueber, Susann
Deiters, Barthold
Klohn, Florian
Kühlein, Thomas
- DOI
-
10.1186/s12959-022-00389-9
- URN
-
urn:nbn:de:bvb:29-opus4-215959
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Warkentin, Lisette
- Hueber, Susann
- Deiters, Barthold
- Klohn, Florian
- Kühlein, Thomas
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?
Prediction of phenprocoumon maintenance dose and phenprocoumon plasma concentration by genetic and non-genetic parameters
Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
Comparison of the efficacy and risk of therapy with the vitamin K antagonist Phenprocoumon with new oral anticoagulants in catheter ablation of atrial fibrillation
Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding
Drug interaction: Omeprazole and Phenprocoumon
Rivaroxaban and other non-vitamin K antagonist oral anticoagulants in the emergency treatment of thromboembolism
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis
Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All?